Literature DB >> 17240656

Stepwise gatekeeping procedures in clinical trial applications.

Alex Dmitrienko1, Ajit C Tamhane, Xin Wang, Xun Chen.   

Abstract

This paper discusses multiple testing problems in which families of null hypotheses are tested in a sequential manner and each family serves as a gatekeeper for the subsequent families. Gatekeeping testing strategies of this type arise frequently in clinical trials with multiple objectives, e.g., multiple endpoints and/or multiple dose-control comparisons. It is demonstrated in this paper that the parallel gatekeeping procedure of Dmitrienko, Offen and Westfall (2003) admits a simple stepwise representation (n null hypotheses can be tested in n steps rather than 2n steps required in the closed procedure). The stepwise representation considerably simplifies the implementation of gatekeeping procedures in practice and provides an important insight into the nature of gatekeeping inferences. The derived stepwise gatekeeping procedure is illustrated using clinical trial examples.

Entities:  

Mesh:

Year:  2006        PMID: 17240656     DOI: 10.1002/bimj.200610274

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  5 in total

1.  In-Hospital Management of Sleep Apnea During Heart Failure Hospitalization: A Randomized Controlled Trial.

Authors:  Rami N Khayat; Shahrokh Javaheri; Kyle Porter; Angela Sow; Roger Holt; Winfried Randerath; William T Abraham; David Jarjoura
Journal:  J Card Fail       Date:  2020-06-24       Impact factor: 5.712

2.  Platelet count mediates the contribution of a genetic variant in LRRC16A to ARDS risk.

Authors:  Yongyue Wei; Zhaoxi Wang; Li Su; Feng Chen; Paula Tejera; Ednan K Bajwa; Mark M Wurfel; Xihong Lin; David C Christiani
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

3.  The minimum intensity of a mixed exposure that increases the risk of an outcome.

Authors:  Ionut Bebu; Barbara H Braffett; John M Lachin
Journal:  Stat Med       Date:  2020-09-03       Impact factor: 2.373

4.  Family Access to a Dentist Study (FADS): A multi-center randomized controlled trial.

Authors:  Suchitra Nelson; Christine Riedy; Jeffrey M Albert; Wonik Lee; Mary Beth Slusar; Shelley Curtan; Gerald Ferretti; Joana Cunha-Cruz; Peter Milgrom
Journal:  Contemp Clin Trials       Date:  2015-10-20       Impact factor: 2.226

5.  Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603).

Authors:  Roberto A Leon-Ferre; Paul J Novotny; Eric G Wolfe; Stephanie S Faubion; Kathryn J Ruddy; Daniel Flora; Christopher S R Dakhil; Kendrith M Rowland; Mark L Graham; Nguyet Le-Lindqwister; Thomas J Smith; Charles L Loprinzi
Journal:  JNCI Cancer Spectr       Date:  2019-10-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.